Page 40 - American Association for Cancer Research

Oncology & Cancer

Breast cancer resistance to CDK4/6 inhibitors arises in many ways

Breast cancer cells became resistant to therapeutics targeting CDK4/6, such as palbociclib (Ibrance), in multiple ways, and preclinical studies suggested different combinations of therapeutics may prevent and overcome the ...

Oncology & Cancer

Cancer immunotherapy a top trend in health care in 2015

This year has been a momentous year in health care, and, as some news outlets like Boston's WBUR radio are reporting, one of the biggest successes is the explosion of cancer immunotherapy. The American Association for Cancer ...

page 40 from 40